These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37441211)

  • 41. Number needed to treat with intravenous tenecteplase to reduce the need for mechanical thrombectomy in large vessel occlusion acute ischemic stroke patients: A retrospective look at real-world experience data.
    Platko S; Bensabeur F; Peters D; Darwich N; Rotsching N; Wagner J; Ugur U; Reynolds S; Terry JB; Cheng-Ching E
    J Clin Neurosci; 2024 Aug; 126():143-147. PubMed ID: 38879957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intra-arterial tenecteplase for treatment of acute ischemic stroke: feasibility and comparative outcomes.
    Georgiadis AL; Memon MZ; Shah QA; Vazquez G; Tariq NA; Suri MF; Taylor RA; Qureshi AI
    J Neuroimaging; 2012 Jul; 22(3):249-54. PubMed ID: 21883621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implementation of a Tenecteplase Protocol for Treatment of Acute Ischemic Stroke in a Health System.
    Pace A; Wai M; Frye E
    Innov Pharm; 2024; 15(1):. PubMed ID: 38779109
    [No Abstract]   [Full Text] [Related]  

  • 44. Conversion From Intravenous Alteplase to Tenecteplase for Treatment of Acute Ischemic Stroke Across a Large Community Hospital Health System.
    Dittmar E; Wolfel T; Menendez L; Pozo J; Ramirez M; Belnap SC; De Los Rios La Rosa F
    Ann Pharmacother; 2023 Oct; 57(10):1147-1153. PubMed ID: 36688289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Moving From Alteplase to Tenecteplase for Acute Ischemic Stroke: Mayo Clinic Experience.
    Koriesh A; Liu M; Brinjikji W; Klaas J; Nasr D; Keser Z
    Neurologist; 2024 Jan; 29(1):50-53. PubMed ID: 37839078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
    Huang X; Cheripelli BK; Lloyd SM; Kalladka D; Moreton FC; Siddiqui A; Ford I; Muir KW
    Lancet Neurol; 2015 Apr; 14(4):368-76. PubMed ID: 25726502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tenecteplase for Acute Ischemic Stroke Treatment.
    Baird AE; Jackson R; Jin W
    Semin Neurol; 2021 Feb; 41(1):28-38. PubMed ID: 33472268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional Outcome and Hemorrhage Rates After Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core.
    Gerschenfeld G; Turc G; Obadia M; Chausson N; Consoli A; Olindo S; Caroff J; Marnat G; Blanc R; Ben Hassen W; Seners P; Guillon B; Wiener E; Bourcier R; Yger M; Cho TH; Checkouri T; Gory B; Smadja D; Sibon I; Richard S; Piotin M; Eker OF; Pico F; Lapergue B; Alamowitch S;
    Neurology; 2024 Jul; 103(1):e209398. PubMed ID: 38862134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Real-world comparative safety and efficacy of tenecteplase
    Psychogios K; Palaiodimou L; Katsanos AH; Magoufis G; Safouris A; Kargiotis O; Spiliopoulos S; Papageorgiou E; Theodorou A; Voumvourakis K; Broutzos E; Stamboulis E; Tsivgoulis G
    Ther Adv Neurol Disord; 2021; 14():1756286420986727. PubMed ID: 33488774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review.
    Zhu A; Rajendram P; Tseng E; Coutts SB; Yu AYX
    Res Pract Thromb Haemost; 2022 Aug; 6(6):e12795. PubMed ID: 36186106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
    Logallo N; Novotny V; Assmus J; Kvistad CE; Alteheld L; Rønning OM; Thommessen B; Amthor KF; Ihle-Hansen H; Kurz M; Tobro H; Kaur K; Stankiewicz M; Carlsson M; Morsund Å; Idicula T; Aamodt AH; Lund C; Næss H; Waje-Andreassen U; Thomassen L
    Lancet Neurol; 2017 Oct; 16(10):781-788. PubMed ID: 28780236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
    Menon BK; Buck BH; Singh N; Deschaintre Y; Almekhlafi MA; Coutts SB; Thirunavukkarasu S; Khosravani H; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar J; Williams H; Field TS; Manosalva A; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Demchuk AM; Mishra S; Gioia LC; Jalini S; Cayer C; Phillips S; Elamin E; Shoamanesh A; Subramaniam S; Kate M; Jacquin G; Camden MC; Benali F; Alhabli I; Bala F; Horn M; Stotts G; Hill MD; Gladstone DJ; Poppe A; Sehgal A; Zhang Q; Lethebe BC; Doram C; Ademola A; Shamy M; Kenney C; Sajobi TT; Swartz RH;
    Lancet; 2022 Jul; 400(10347):161-169. PubMed ID: 35779553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in the management of acute ischemic stroke.
    Nair R; Wagner AN; Buck BH
    Curr Opin Neurol; 2023 Apr; 36(2):147-154. PubMed ID: 36762632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase.
    Szabo S; Letsch R; Ehlers R; Walter T; Kazmaier S; Helber U; Hoffmeister HM
    Thromb Res; 2002 Apr; 106(2):113-9. PubMed ID: 12182909
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tenecteplase versus alteplase for large vessel occlusion recanalization (T-FLAVOR): Trial protocol.
    Kawano H; Hirano T; Inoue M; Fukuda-Doi M; Iwasaki K; Omae K; Tanaka K; Yamamoto H; Koga M; Sakai N; Nagao T; Sasaki M; Hayakawa N; Toyoda K
    Eur Stroke J; 2022 Mar; 7(1):71-75. PubMed ID: 35300254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous thrombolysis with tenecteplase versus alteplase combined with endovascular treatment of anterior circulation tandem occlusions: A pooled analysis of ETIS and TETRIS.
    Marnat G; Lapergue B; Gory B; Kyheng M; Labreuche J; Turc G; Olindo S; Sibon I; Caroff J; Smadja D; Chausson N; Clarençon F; Seners P; Bourcier R; Pop R; Olivot JM; Mazighi M; Moulin S; Janot K; Cognard C; Alamowitch S; Gerschenfeld G
    Eur Stroke J; 2024 Mar; 9(1):124-134. PubMed ID: 37837202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tenecteplase Thrombolysis for Acute Ischemic Stroke.
    Warach SJ; Dula AN; Milling TJ
    Stroke; 2020 Nov; 51(11):3440-3451. PubMed ID: 33045929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
    Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
    Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous Thrombolysis with Tenecteplase for the Treatment of Acute Ischemic Stroke.
    Tsivgoulis G; Katsanos AH; Christogiannis C; Faouzi B; Mavridis D; Dixit AK; Palaiodimou L; Khurana D; Petruzzellis M; Psychogios K; Macleod MJ; Ahmed N
    Ann Neurol; 2022 Sep; 92(3):349-357. PubMed ID: 35713213
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.